Dr. Itzik Harosh is the founder & CEO of ObeTherapy Biotechnology in Genopole at Evry, France. He received his Ph.D. in the Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel in 1987 and M.Sc. in the Department of Biochemistry, Faculty of Agriculture, The Hebrew University of Jerusalem, Israel. Dr. Harosh honored with Dean's Award - Stanford University Medical School, Stanford University, Stanford CA in 1988 and Fancony Anemia Research Foundation Fellowship - University of California, Davis, CA in 1989. Dr. Itzik Harosh's research interests includes Negotiate and close deals between ObeTherapy and other biotech and pharmaceutical companies, Expert in obesity, diabetes, lipidemia, and metabolic syndrome. In depth knowledge in drug discovery, target identification and validation, etc.